Clinical Trials Logo

Cellulite clinical trials

View clinical trials related to Cellulite.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT05885035 Completed - Cellulite Clinical Trials

Effects of Calcium Hydroxylapatite on Cellulite Dimples in the Buttocks

Start date: January 1, 2023
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to test the efficacy of Calcium Hydroxylapatite (CaHA) in treating cellulite dimples in the buttocks. Participants will: - have 3 treatment sessions at weeks 0, 4, and 8 and a final live assessment visit at week 14 - receive approximately 2 syringes per side of the buttocks, per treatment session - have their pictures taken before and after each treatment session, and once more during the final visit

NCT ID: NCT05882721 Completed - Cellulite Clinical Trials

Treatment for Improvement of Cellulite Appearance Using Form Applicator

Start date: February 20, 2023
Phase: N/A
Study type: Interventional

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.

NCT ID: NCT05836779 Completed - Cellulite Clinical Trials

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)

Start date: May 10, 2023
Phase: Phase 2
Study type: Interventional

The Stage 2 of this phase 2 study is an open-label, single-arm study to assess the efficacy and safety of CBL-514 in participants with Edematous Fibrosclerotic Panniculopathy (EFP) cellulite.

NCT ID: NCT05632926 Completed - Cellulite Clinical Trials

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 1)

Start date: January 9, 2023
Phase: Phase 2
Study type: Interventional

The Stage 1 of this phase 2 study is an open-label single ascending dose (SAD) study to assess the efficacy and safety of CBL-514 in participants with Edematous Fibrosclerotic Panniculopathy (EFP) cellulite.

NCT ID: NCT05624216 Completed - Cellulitis Clinical Trials

Radiofrequency and Targeted Pressure Energy for Cellulite Reduction

Start date: July 30, 2019
Phase: N/A
Study type: Interventional

This study will evaluate the clinical efficacy and safety of radiofrequency heating and targeted pressure energy for reduction in the appearance or cellulite. The study is a prospective multi-center open-label single-arm study. Subjects will be required to complete four (4) treatment visits and two to three follow-up visits - 1, 3 and 6 months after the last therapy visit. All of the study subjects will receive the treatment with the subject device.

NCT ID: NCT05419505 Completed - Cellulite Clinical Trials

Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks

APHRODITE
Start date: June 15, 2022
Phase: Phase 2
Study type: Interventional

The study will evaluate the effect of different doses, strengths (concentrations), diluent additives, depths of injection, and methods of injection on the severity of bruising potentially induced by QWO (collagenase clostridium histolyticum-aaes [CCH-aaes]).

NCT ID: NCT05358847 Completed - Cellulite Clinical Trials

Treatment for Cellulite Appearance

Start date: November 21, 2021
Phase: N/A
Study type: Interventional

Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.

NCT ID: NCT05309525 Completed - Cellulite Clinical Trials

Effect of Oral TXA on Buttock Bruising Post CCH Injections in Adult Females

Start date: April 22, 2022
Phase: Phase 4
Study type: Interventional

This is an open-label, randomized, multiple dose IIR study to evaluate the effect of Lysteda™ on bruising following QWO™ injections to the buttocks in female subjects presenting with moderate to severe cellulite. Following determination of eligibility based on inclusion/exclusion assessment, the subjects will be randomized to either Cohort A, Cohort B, or Cohort C, based on order of enrollment. Each Cohort will receive 3 Qwo™ treatments spaced 21 days apart, with 1300 mg of Lysteda™ TID PO at one, two, or all three treatments of Qwo™. Cohort A will be given tranexamic acid at the first treatment, Cohort B at the first and second treatment, and Cohort C at all three treatments. All buttock CCH injections will follow the on-label injection protocol. Subjects will participate in the study for 65 days total, with an additional screening period of 14 days. There will be a total of 11 visits (Screening, Day 1, Day 4, Day 14, Day 22, Day 26, Day 36, Day 43, Day 47, Day 57, Day 65).

NCT ID: NCT05249257 Completed - Cellulite Clinical Trials

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Start date: January 25, 2022
Phase:
Study type: Observational

All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.

NCT ID: NCT05199506 Completed - Cellulite Clinical Trials

Study to Evaluate the Safety and Effectiveness of the RAP Device for the Improvement in the Appearance of Cellulite

Start date: May 4, 2021
Phase: N/A
Study type: Interventional

The purpose of this single site clinical study is to evaluate the safety and effectiveness of the Soliton Rapid Acoustic Pulse (RAP) device for the improvement of cellulite comparing two different RAP treatment doses.